Status:
UNKNOWN
SGLT2 Inhibitors Prophylaxis Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease?
Lead Sponsor:
Fayoum University
Collaborating Sponsors:
Cairo University
Conditions:
SGLT2i Kideny Protection Against Contrast in Diabetic Kidney
Eligibility:
All Genders
30+ years
Brief Summary
We will look for the possible effect of SGLT2i as a single agent to prevent post-contrast Acute Kidney Injury in diabetic kidney disease.
Detailed Description
Population of Study o Group 1 : 1. st group will receive normal saline 10ml/kg over 6 hours before and 6 hours after radiocontrast. o Group 2 : 2. nd group will receive allopurinol 300 mg and lin...
Eligibility Criteria
Inclusion
- Age: more than30years, Diabetes, Diabetic kidney disease, GFR: more than30ml/min/1.73m2
Exclusion
- Diabetics Patients with GFR less than 30 mL/min/1.73 m2.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04853615
Start Date
July 1 2021
End Date
August 1 2024
Last Update
April 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.